Monoclonal Mouse anti‑Human SH3BGR Antibody (clone 3B7, IHC, WB) LS‑C133435
Monoclonal Mouse anti‑Human SH3BGR Antibody (clone 3B7, IHC, WB) LS‑C133435
Antibody:
SH3BGR Mouse anti-Human Monoclonal (3B7) Antibody
Application:
IHC, IHC-P, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
SH3BGR Mouse anti-Human Monoclonal (3B7) Antibody
Application:
IHC, IHC-P, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
SH3BGR antibody LS-C133435 is an unconjugated mouse monoclonal antibody to human SH3BGR. Validated for ELISA, IHC and WB.
Target
Human SH3BGR
Synonyms
SH3BGR | 21-GARP | 21-glutamic acid-rich protein | SH3GBR | SH3BGR protein
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1,k
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites by Protein A
Immunogen
SH3BGR (AAH06371, 1 aa ~ 240 aa) full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Applications
- IHC
- IHC - Paraffin (3 µg/ml)
- Western blot
- ELISA
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Immunohistochemistry: Formalin-fixed paraffin-embedded sections. Sandwich ELISA: Recombinant protein. Western Blot: Cell lysate, Recombinant protein.
Storage
Store at -20°C or lower. Aliquot to avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Reactivity:
Mouse
Range:
0.156-10 ng/ml
Reactivity:
Human
Range:
0.78-50 ng/ml
Reactivity:
Rat
Range:
0.156-10 ng/ml
Reactivity:
Human, Mouse, Rat
Range:
Positive/Negative
Species:
Human
Applications:
IHC - Paraffin, Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/19/2024